- Home
- Publications
- Publication Search
- Publication Details
Title
Natural products as lead compounds in drug discovery
Authors
Keywords
-
Journal
JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH
Volume 15, Issue 7, Pages 764-788
Publisher
Informa UK Limited
Online
2013-05-23
DOI
10.1080/10286020.2013.798314
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Population pharmacokinetic/pharmacodynamic modeling of drug-induced adverse effects of a novel homocamptothecin analog, elomotecan (BN80927), in a Phase I dose finding study in patients with advanced solid tumors
- (2012) Iñaki F. Trocóniz et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- A phase II trial of oral gimatecan for recurrent glioblastoma
- (2012) Jethro Hu et al. JOURNAL OF NEURO-ONCOLOGY
- The impact of the United Nations Convention on Biological Diversity on natural products research
- (2012) Gordon M. Cragg et al. NATURAL PRODUCT REPORTS
- Inhibition of hyaluronan retention by 4-methylumbelliferone suppresses osteosarcoma cells in vitro and lung metastasis in vivo
- (2011) E Arai et al. BRITISH JOURNAL OF CANCER
- Selective Overproduction of the Proteasome Inhibitor Salinosporamide A via Precursor Pathway Regulation
- (2011) Anna Lechner et al. CHEMISTRY & BIOLOGY
- Preclinical and clinical activity of the topoisomerase I inhibitor, karenitecin, in melanoma
- (2011) Pamela N Munster et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- The anti-tumor drug E7107 reveals an essential role for SF3b in remodeling U2 snRNP to expose the branch point-binding region
- (2011) E. G. Folco et al. GENES & DEVELOPMENT
- Romidepsin (Istodax, NSC 630176, FR901228, FK228, depsipeptide): a natural product recently approved for cutaneous T-cell lymphoma
- (2011) Karen M VanderMolen et al. JOURNAL OF ANTIBIOTICS
- Fingolimod (FTY720): A Recently Approved Multiple Sclerosis Drug Based on a Fungal Secondary Metabolite
- (2011) Cherilyn R. Strader et al. JOURNAL OF NATURAL PRODUCTS
- Phase 3 study of docosahexaenoic acid-paclitaxel versus dacarbazine in patients with metastatic malignant melanoma
- (2010) A. Y. Bedikian et al. ANNALS OF ONCOLOGY
- Identification of the Human UDP-Glucuronosyltransferases Involved in the Glucuronidation of Combretastatin A-4
- (2010) S. Aprile et al. DRUG METABOLISM AND DISPOSITION
- K252a induces anoikis-sensitization with suppression of cellular migration in Epstein-Barr Virus (EBV)—associated nasopharyngeal carcinoma cells
- (2010) Yuen-Keng Ng et al. INVESTIGATIONAL NEW DRUGS
- Phase IIB Trial of Oral Midostaurin (PKC412), the FMS-Like Tyrosine Kinase 3 Receptor (FLT3) and Multi-Targeted Kinase Inhibitor, in Patients With Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome With Either Wild-Type or Mutated FLT3
- (2010) Thomas Fischer et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized Multicenter Phase II Study of Larotaxel (XRP9881) in Combination with Cisplatin or Gemcitabine as First-Line Chemotherapy in Nonirradiable Stage IIIB or Stage IV Non-small Cell Lung Cancer
- (2010) Petr Zatloukal et al. Journal of Thoracic Oncology
- Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis
- (2010) Volker Brinkmann et al. NATURE REVIEWS DRUG DISCOVERY
- The Protein Kinase C Agonist PEP005 (Ingenol 3-Angelate) in the Treatment of Human Cancer: A Balance between Efficacy and Toxicity
- (2010) Elisabeth Ersvaer et al. Toxins
- Phase II of oral gimatecan in patients with recurrent epithelial ovarian, fallopian tube or peritoneal cancer, previously treated with platinum and taxanes
- (2009) S. Pecorelli et al. ANNALS OF ONCOLOGY
- The Changing Face of HDAC Inhibitor Depsipeptide
- (2009) Wen Zhou et al. CURRENT CANCER DRUG TARGETS
- Dysoxylum binectariferum Hook.f (Meliaceae), a rich source of rohitukine
- (2009) Patel Mohanakumara et al. FITOTERAPIA
- Role of the PI3K/AKT and mTOR signaling pathways in acute myeloid leukemia
- (2009) S. Park et al. HAEMATOLOGICA
- Fumagillin inhibits colorectal cancer growth and metastasis in mice:In vivoandin vitrostudy of anti-angiogenesis
- (2009) Li Hou et al. PATHOLOGY INTERNATIONAL
- Epothilones in prostate cancer
- (2009) William K. Kelly UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- In vitro hepatic conversion of the anticancer agent nemorubicin to its active metabolite PNU-159682 in mice, rats and dogs: A comparison with human liver microsomes
- (2008) Luigi Quintieri et al. BIOCHEMICAL PHARMACOLOGY
- Evaluation of silibinin on the viability, migration and adhesion of the human prostate adenocarcinoma (PC-3) cell line
- (2008) M MOKHTARI et al. CELL BIOLOGY INTERNATIONAL
- Curcumin: From ancient medicine to current clinical trials
- (2008) H. Hatcher et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- The Epothilones: Translating from the Laboratory to the Clinic
- (2008) J. J. Lee et al. CLINICAL CANCER RESEARCH
- Enzastaurin
- (2008) Yi-Bin Chen et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Diflomotecan, a promising homocamptothecin for cancer therapy
- (2008) Judith R Kroep et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Effects of EDP-420 on penicillin-resistant and quinolone- and penicillin-resistant pneumococci in the rabbit meningitis model
- (2008) A. Stucki et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Osteosarcoma: The Addition of Muramyl Tripeptide to Chemotherapy Improves Overall Survival—A Report From the Children's Oncology Group
- (2008) Paul A. Meyers et al. JOURNAL OF CLINICAL ONCOLOGY
- Natural products to drugs: natural product-derived compounds in clinical trials
- (2008) Mark S. Butler NATURAL PRODUCT REPORTS
- A simple and reproducible 96-well plate-based method for the formation of fungal biofilms and its application to antifungal susceptibility testing
- (2008) Christopher G Pierce et al. Nature Protocols
- Epothilones: tubulin polymerization as a novel target for prostate cancer therapy
- (2008) James J Lee et al. Nature clinical practice. Oncology
- Faropenem Medoxomil
- (2007) Jacob P Gettig et al. ANNALS OF PHARMACOTHERAPY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started